Busitema University's Faculty of Health Sciences, located in Mbale, has achieved a significant breakthrough in their endeavors to develop herbal drugs for the management of Covid-19. Spearheaded by a team of dedicated scientists, these drugs are currently undergoing clinical trials at the renowned Makerere University Lung Institute. The promising lineup of medications includes Tazcov nasal spray, Tazcon syrup, and Tazcov pulmonary spray.

Harnessing the potent medicinal properties of indigenous plants sourced from the Teso and Mt Elgon sub-regions, these products have been meticulously formulated to contain antiviral and anti-inflammatory agents. Led by esteemed figures in the field such as Prof Mary Okwakol and Dr Samuel Baker Obakiro, the Busitema University team has focused their expertise on crafting effective solutions against the ongoing Covid-19 pandemic.

By tapping into the rich natural resources of the local environment, Busitema University's scientists have not only showcased the potential of traditional medicine but have also paved the way for innovative approaches in combating the virus. The ongoing clinical trials at the esteemed Makerere University Lung Institute serve as a testament to the rigorous testing and validation processes undertaken to ensure the safety and efficacy of these herbal drugs.

This groundbreaking development holds immense promise for the future of Covid-19 management, as the herbal drugs being developed by Busitema University's Faculty of Health Sciences could potentially offer alternative treatment options. As the clinical trials progress, the scientific community eagerly awaits the results, hoping for a breakthrough that could significantly contribute to the global fight against the pandemic.